EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease



Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease



Japanese Journal of Cancer Research 76(5): 374-377



Selenium concentrations in whole blood of Japanese and American women with and without breast cancer and benign fibrocystic breast disease were determined. The observed blood Se levels of healthy Japanese women (0.286 +/- 0.021 micrograms/ml) were similar to previously reported values for healthy Japanese adults. The Japanese patients with benign breast disease and with breast cancer exhibited blood selenium concentrations of 0.200 +/- 0.045 and 0.195 +/- 0.057 micrograms/ml, respectively. The mean blood Se concentration of Japanese breast cancer patients with recurrence was 0.188 +/- 0.061 micrograms/ml. The mean blood Se concentrations of healthy American women from San Diego, Calif., were 0.191 +/- 0.023 micrograms/ml; of women with benign fibrocystic disease, 0.142 +/- 0.010 micrograms/ml; and of breast cancer patients, 0.167 +/- 0.032 micrograms/ml. The higher blood Se concentrations of Japanese healthy subjects as compared to healthy Americans can be attributed to differences in the dietary Se intakes; low blood Se concentration may be indicative of increased breast cancer risk.

(PDF emailed within 1 workday: $29.90)

Accession: 006385329

Download citation: RISBibTeXText

PMID: 3924710



Related references

Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease. Selenium in biology and medicine: proceedings of the Third International Symposium on Selenium in Biology and Medicine held May 27 June 1-1984 Xiangshan Fragrance Hills Hotel Beijing People's Re ic of China: -1121, 1987

Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast. Cancer Research 38(9): 3051-3054, 1978

Angiogenesis and risk of breast cancer in women with fibrocystic disease. Journal of the National Cancer Institute 86(8): 635-636, 1994

Serum and breast duct fluid prolactin and estrogen levels in healthy Finnish and American women and patients with fibrocystic disease. Cancer 57(8): 1550-1554, 1986

Molecular heterogeneity of serum prolactin in women with fibrocystic disease and breast cancer. Journal of Gynaecological Endocrinology 2(1-2): 11-16, 1986

It does matter: breast cancer is the second leading cause of cancer deaths in American women (American Cancer Society, 2008). Assuming an average life span of 85 years, one in eight U.S. women will be diagnosed with breast cancer. Nursing for Women's Health 14(1): 34-41, 2010

The role of diet in the development of breast cancer: a case-control study of patients with breast cancer, benign epithelial hyperplasia and fibrocystic disease of the breast. British Journal of Cancer 64(1): 187-191, 1991

Critical, morphological, and histopathogenic considerations on fibrocystic breast disease; fibrocystic disease and carcinoma of the breast. Archivio Italiano di Anatomia E Istologia Patologica 24(6): 473-514, 1951

Changing incidence of breast cancer in Japanese-American women. Journal of the National Cancer Institute 51(5): 1479-1483, 1973

Selenium and human lactation in Australia: milk and blood selenium levels in lactating women, and selenium intakes of their breast-fed infants. Acta Paediatrica 81(4): 292-295, 1992

Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China. Cancer Epidemiology, Biomarkers & Prevention 16(12): 2579-2586, 2007

Glutathione S-transferase M1 and P1 polymorphisms and risk of breast cancer and fibrocystic breast conditions in Chinese women. Breast Cancer Research and Treatment 109(1): 143-155, 2007

Plasma equol concentration is not associated with breast cancer and fibrocystic breast conditions among women in Shanghai, China. Nutrition Research 36(8): 863-871, 2016

Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China. Cancer Epidemiology, Biomarkers & Prevention 17(12): 3457-3466, 2008

Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women. Cancer Epidemiology, Biomarkers & Prevention 17(5): 1066-1073, 2008